Alfasigma S.p.A.

Industry / private company


Location: Bologna, Italy (IT) IT

ROR: https://ror.org/02n5pfm79

Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy (2018) Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, et al. Journal article